Log In
BCIQ
Print this Print this
 

CYC065

  Manage Alerts
Collapse Summary General Information
Company Cyclacel Pharmaceuticals Inc.
DescriptionSecond-generation inhibitor of cyclin dependent kinase 2 (CDK2), CDK5 and CDK9
Molecular Target Cyclin dependent kinase 2 (CDK2) ; Cyclin dependent kinase 9 (CDK9)
Mechanism of ActionCyclin dependent kinase (CDK) inhibitor
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today